Condition 101 About Myositis

What is the definition of Myositis?

Myositis is an inflammation or swelling of the muscles. It is most often caused by injury, infection, medicines, or an autoimmune disorder.

Dermatomyositis and polymyositis are related topics.

What are the alternative names for Myositis?

Inflammatory myopathies

REFERENCES

Amato AA. Disorders of the skeletal muscle. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL, eds. Bradley's Neurology in Clinical Practice. 7th ed. Philadelphia, PA: Elsevier; 2016:chap 110.

Greenberg SA. Inflammatory myopathies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 269.

Taber's Medical Dictionary Online. Myositis. www.tabers.com/tabersonline/view/Tabers-Dictionary/729759/all/myositis. Accessed June 10, 2019.

Latest Advances On Myositis

  • Condition: Shrinking Lung Syndrome in Pediatric Systemic Lupus Erythematosus
  • Journal: Pediatric rheumatology online journal
  • Treatment Used: Rituximab
  • Number of Patients: 1
  • Published —
The study researched the outcomes of using rituximab to treat shrinking lung syndrome in pediatric systemic lupus erythematosus.
  • Condition: Ulcerative Colitis with Dermatomyositis
  • Journal: World journal of gastroenterology
  • Treatment Used: Infliximab
  • Number of Patients: 1
  • Published —
In this study, researchers evaluated the outcomes of using infliximab to treat a patient who had ulcerative colitis with dermatomyositis.

Clinical Trials For Myositis

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 27
  • Start Date: April 2021
A Phase 1, Open-Label, Ascending Dose Study of ABC008 in Adult Patients With Inclusion
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 76
  • Start Date: February 5, 2021
Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease : Multicentric Randomized Phase III Trial